HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
THURSDAY, Sept. 24, 2015 (HealthDay News) -- For patients in intensive care units who need a catheter, placement in the subclavian vein appears to lower the risk of bloodstream infection and deep-vein thrombosis, compared to jugular or femoral placement, a new study finds. The report was published in the Sept. 24 issue of the New England Journal of Medicine.
For the study, researchers randomly assigned 3,027 patients to have catheters placed in one of three locations: nontunneled central venous catheterization to the subclavian, jugular, or femoral vein. The primary outcome measure was a composite of catheter-related bloodstream infection and symptomatic deep-vein thrombosis.
The researchers found subclavian-vein catheterization was associated with a lower risk of bloodstream infection and symptomatic thrombosis than jugular or femoral-vein catheterization. However, subclavian-vein placement was also associated with a higher risk of pneumothorax.
Lead researcher Jean-Jacques Parienti, M.D., Ph.D., from the department of biostatistics and clinical research at Cote de Nacre University Hospital in Caen France, told HealthDay that "the subclavian route is the safest for the patient, provided that everything is done to reduce the risk of mechanical complications during insertion."
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 31, 2022